Skip to main content

Rondoni John's Form 4 filing

Inspire Medical Systems, Inc.INSP · filed Jan 12, 2026

Accession no.
0001104659-26-002864
Filed
Jan 12, 2026
Trade date
Jan 9, 2026
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 1 non-derivative transaction. Open-market sales total $10.9K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rondoni JohnCIK 0001932219Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 9, 2026Common StockSSaleDisposed−109$100.00−$10,90013,797Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

Title: Chief Product and Innovation Officer. All sale transactions reported herein were made pursuant to a Rule 10b5-1 trading plan dated May 28, 2025.

Read the full filing on SEC EDGAR (opens in a new tab)